Skip to main content
Premium Trial:

Request an Annual Quote

Quanterix Gets Investment from In-Q-Tel

NEW YORK (GenomeWeb News) – Quanterix today said that it has received an investment from In-Q-Tel, an independent strategic investment firm that identifies technologies that support the missions of the US intelligence community, to support further development of its Single Molecule Array (SiMoA) technology.

Cambridge, Mass.-based Quanterix said that it would work with In-Q-Tel to develop its platform to enable simultaneous measurement of both nucleic acids and proteins for the detection of pathogens. It said that SiMoA will "facilitate the direct and non-amplified detection of pathogens to obtain a level of sensitivity that could previously only be achieved with amplification methods."

Quanterix did not disclose the amount of the investment by In-Q-Tel.

"The ability to accurately detect the presence of low abundance molecules makes Quanterix technology a critical addition to our strategic investment portfolio," Syd Ulvick, VP of physical and biological technologies practice at In-Q-Tel, said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.